NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Evaluating Effectiveness and Long Term Safety of Damoctocog Alfa Pegol in Patients, Who Have Been Diagnosed With Hemophilia A

NCT03932201

Active Not RecruitingN/A

Sponsor: Bayer

Conditions: Hemophilia A

Interventions: Damoctocog alfa pegol (Jivi, Bay94-9027)

Countries: United States, Belgium, Brazil, Canada, Colombia, Denmark, Germany, Greece

The aim of the HEM-POWR study is to understand better how Damoctocog alfa pegol (Jivi) is used to treat people with Hemophilia A in day-to-day life, how well the treatment is tolerated and how satisfied patients and physicians are with the treatment.

Eligibility overview

Sex: ALL

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Diagnosis of hemophilia A.
* Patients previously treated for Hemophilia A.
* Patients without previous history of inhibitors or patients with previous history of inhibitors on standard prophylaxis therapy for at least 1 year prior to study entry.
* No current evidence of FVIII inhibitor or clinical suspicion of FVIII inhibitor.
* Initiation of or currently on damoctocog alfa pegol with any kind of treatment modality (on-demand, prophylaxis, or intermittent prophylaxis).
* Signed informed consent/assent.

Exclusion Criteria:

* Concurrent participation in an investigational program with interventions outside of routine clinical practice.
* Diagnosis of any other bleeding/coagulation disorder other than hemophilia A.
* Contra-indications according to the local marketing authorization.
* Patient on immune tolerance induction (ITI) treatment at the time of enrollment.

Locations (29)

Mobile, Alabama, United States
Phoenix, Arizona, United States
Davis, California, United States
Los Angeles, California, United States
Orange, California, United States
Aurora, Colorado, United States
Washington D.C., District of Columbia, United States
New Orleans, Louisiana, United States
Minneapolis, Minnesota, United States
Greenville, North Carolina, United States
Multiple Locations, Belgium
Multiple Locations, Brazil
Multiple Locations, Canada
Multiple Locations, Colombia
Multiple Locations, Denmark
Multiple Locations, Germany
Multiple Locations, Greece
Multiple Locations, Italy
Multiple Locations, Japan
Multiple Locations, Kuwait
Multiple Locations, Netherlands
Multiple Locations, Norway
Multiple Locations, Saudi Arabia
Multiple Locations, Slovenia
Multiple Locations, Spain
Multiple Locations, Sweden
Multiple Locations, Switzerland
Multiple Locations, Taiwan
Multiple Locations, United Arab Emirates